ATE174889T1 - Verfahren zur optischen spaltung von antipoden durch kristallisierung - Google Patents

Verfahren zur optischen spaltung von antipoden durch kristallisierung

Info

Publication number
ATE174889T1
ATE174889T1 AT94928427T AT94928427T ATE174889T1 AT E174889 T1 ATE174889 T1 AT E174889T1 AT 94928427 T AT94928427 T AT 94928427T AT 94928427 T AT94928427 T AT 94928427T AT E174889 T1 ATE174889 T1 AT E174889T1
Authority
AT
Austria
Prior art keywords
pct
enantiomer
solution
sec
optical
Prior art date
Application number
AT94928427T
Other languages
English (en)
Inventor
Gerard Coquerel
Marie-Noelle Petit
Roger Bouaziz
Original Assignee
Univ Rouen
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Rouen filed Critical Univ Rouen
Application granted granted Critical
Publication of ATE174889T1 publication Critical patent/ATE174889T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/76—Two oxygen atoms, e.g. hydantoin with substituted hydrocarbon radicals attached to the third ring carbon atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B57/00—Separation of optically-active compounds
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/74—Separation; Purification; Use of additives, e.g. for stabilisation
    • C07C29/76—Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment
    • C07C29/78—Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment by condensation or crystallisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/74—Two oxygen atoms, e.g. hydantoin with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to other ring members

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Crystals, And After-Treatments Of Crystals (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Processes Of Treating Macromolecular Substances (AREA)
  • Treatments Of Macromolecular Shaped Articles (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
AT94928427T 1993-09-23 1994-09-22 Verfahren zur optischen spaltung von antipoden durch kristallisierung ATE174889T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9311354A FR2710337B1 (fr) 1993-09-23 1993-09-23 Procédé de dédoublement de deux antipodes optiques par entraînement polythermique programmé et autoensemencé.

Publications (1)

Publication Number Publication Date
ATE174889T1 true ATE174889T1 (de) 1999-01-15

Family

ID=9451175

Family Applications (1)

Application Number Title Priority Date Filing Date
AT94928427T ATE174889T1 (de) 1993-09-23 1994-09-22 Verfahren zur optischen spaltung von antipoden durch kristallisierung

Country Status (9)

Country Link
US (1) US6022409A (de)
EP (1) EP0720595B1 (de)
JP (1) JP3647862B2 (de)
AT (1) ATE174889T1 (de)
DE (1) DE69415545T2 (de)
DK (1) DK0720595T3 (de)
ES (1) ES2128584T3 (de)
FR (1) FR2710337B1 (de)
WO (1) WO1995008522A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0008563D0 (en) * 2000-04-07 2000-05-24 Cambridge Discovery Chemistry Investigating different physical and/or chemical forms of materials
FR2849029B1 (fr) * 2002-12-20 2005-03-18 Lafon Labor Procede de preparation et formes cristallines des enantiomeres optiques du modafinil.
US7368591B2 (en) 2003-09-19 2008-05-06 Cephalon France Process for enantioselective synthesis of single enantiomers of modafinil by asymmetric oxidation
US7501514B1 (en) 2003-10-15 2009-03-10 Shire Biochem, Inc. Enantiomeric resolution of 2-substituted 4-substituted 1,3-oxathiolanes nucleosides
DE102005039501B4 (de) * 2005-08-20 2013-09-12 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Verfahren zur Trennung verbindungsbildender chiraler Systeme
US20080070890A1 (en) * 2006-09-15 2008-03-20 Burnett Duane A Spirocyclic Azetidinone Compounds and Methods of Use Thereof
MX2009002921A (es) * 2006-09-15 2009-04-01 Schering Corp Derivados de azetidinona para el tratamiento de trastornos del metabolismo lipidico.
FR2909380B1 (fr) 2006-12-04 2009-02-20 Sidem Pharma Sa Sa Conglomerats de sels de potassium de tenatoprazole
FR2920428B1 (fr) * 2007-08-29 2012-06-15 Univ Rouen Procede de dedoublement de sels de l'omeprazole
EP2334620B1 (de) 2008-09-05 2018-09-05 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Verfahren zur enantioselektiven trennung chiraler systeme mit verbindungsbildung unter anwendung von zwei aufeinanderfolgenden kristallisationsschritten
WO2010026439A1 (en) * 2008-09-05 2010-03-11 Shire Biochem Inc. Enantiomeric resolution of 2,4-disubstituted 1,3-oxathiolane nucleosides
ES2436633T3 (es) * 2009-03-26 2014-01-03 Poxel Procedimiento para la separación de enantiómeros de dihidro-1,3,5-triazinas racémicas por cristalización preferencial
EP2292306B1 (de) 2009-09-02 2013-05-01 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Verfahren zum Trennen von racemischen verbindungsbildenden chiralen Substanzen durch ein zyklisches Kristallisationsverfahren und eine Kristallisationsvorrichtung
FR2954310B1 (fr) * 2009-12-18 2014-07-25 Univ Rouen Procede de dedoublement d'enantiomeres par evapocristallisation preferentielle
FR3054218B1 (fr) * 2016-07-22 2020-03-06 Universite De Rouen Procede de dedoublement de sels de baclofene
WO2020191163A1 (en) 2019-03-20 2020-09-24 Regeneron Pharmaceuticals, Inc. Treatment of increased lipid levels with sterol regulatory element binding protein cleavage-activating protein (scap) inhibitors
JP7574206B2 (ja) 2019-03-20 2024-10-28 リジェネロン・ファーマシューティカルズ・インコーポレイテッド ステロール調節エレメント結合転写因子1(srebf1)阻害剤による上昇した脂質レベルの治療
WO2025049558A1 (en) 2023-08-29 2025-03-06 Regeneron Pharmaceuticals, Inc. Treatment of liver disease or metabolic disorder with folliculin interacting protein 1 (fnip1) inhibitors and/or folliculin (flcn) inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1456627A (fr) * 1964-07-24 1966-07-08 Asahi Chemical Ind Perfectionnements aux procédés pour la résolution de l'acide glutamique racémique et de ses sels
GB1197809A (en) * 1968-02-13 1970-07-08 Inst Noguchi Method for Continuous Optical Resolution of Organic Racemates.

Also Published As

Publication number Publication date
WO1995008522A1 (fr) 1995-03-30
EP0720595A1 (de) 1996-07-10
JP3647862B2 (ja) 2005-05-18
FR2710337B1 (fr) 1995-12-08
US6022409A (en) 2000-02-08
JPH09506861A (ja) 1997-07-08
EP0720595B1 (de) 1998-12-23
DK0720595T3 (da) 1999-08-23
ES2128584T3 (es) 1999-05-16
DE69415545T2 (de) 1999-09-16
FR2710337A1 (fr) 1995-03-31
DE69415545D1 (de) 1999-02-04

Similar Documents

Publication Publication Date Title
DE69415545D1 (de) Verfahren zur optischen spaltung von antipoden durch kristallisierung
ATE137139T1 (de) Vorrichtung zur herstellung von alginatkugeln
DK289687D0 (da) Fremgangsmaade til fremstilling af l-2-amino-4-(hydroxymethylphosphinyl)-smoeresyre
MY129649A (en) Chiral salt resolution
ATE149483T1 (de) Kristalle von n-(trans-4- isopropylcyclohexylcarbonyl)-d-phenylalanin und verfahren zu ihrer herstellung
ATE219047T1 (de) Verfahren zur herstellung von optisch reinen isomeren des formoterols
DE59609239D1 (de) Verfahren zur abtrennung von mittelsiedern aus einem gemisch aus leicht-, mittel- und hochsiedern
FI924668L (fi) Foerfarande foer framstaellning av vaesentligen ren melfalanhydroklorid
DE3482642D1 (de) Verfahren zur herstellung von recycle-l-zeolith.
ATE5299T1 (de) Kristallisationskolonne und verfahren zum herstellen einer kristallisation in einer solchen kolonne.
BR9408047A (pt) Processo para produção de granulado
DK0759973T3 (da) Fremgangsmåde til klaring af vinase
ATE234823T1 (de) Verfahren zur herstellung von melamin
DE69707142D1 (de) Verfahren zur herstellung von melamin
ES386356A1 (es) Un procedimiento para cristalizar un componente cristaliza-ble a partir de una solucion del mismo.
ATE115089T1 (de) Ammonium sulfat-granulat und verfahren zur herstellung.
ATE325868T1 (de) Verfahren zur schnellen herstellung von crystallen mit wünschenswerter morphologie
ES2075102T3 (es) Procedimiento para la resolucion quimica de (+/-)-1,3-dimetiloxiindoliletilaminas 5-alcoxi sustituidas.
ATE60812T1 (de) Verfahren zur herstellung von kristallen intermetallischer verbindungen, insbesondere einzelner einkristalle, durch abkuehlung von legierungsschmelzen.
ATE22070T1 (de) Verfahren zur herstellung bestimmter enantiomerenpaare von permethrinsaeure -alphacyano-3-phenoxy-4-fluor-benzyl-ester.
ATE325797T1 (de) Verfahren zur herstellung von hochreinem triethylendiamin
DE69605528D1 (de) Verfahren zur kristallisierung aus wasser von (s)-n,n'-bis[2-hydroxy-1-(hydroxymethiel)ethyl]-5-[(2-hydroxy-1-oxopropyl)amino]-2,4,6-triiodo-1,3-benzoldicarboxamide
DE59003987D1 (de) Verfahren zur Entfernung von Ammoniumsulfat aus hochteerhaltigen Abfallströmen der (Meth) Acrylnitrilherstellung.
JPS55115846A (en) Optical resolution of dl-mandelic acid
GB1020696A (en) Resolution of a salt of n-benzoyl serine

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification